Ratings by Benchmark (Bruce Jackson)

Date CompanySymbol Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
3/25/2021 Neogenomics NEO Maintain Buy
(N/A)
 
 
  Details
3/18/2021 Vesper Healthcare VSPR New Coverage Buy
(N/A)
11.22
(12.49)
11.32% Details
3/17/2021 OncoCyte Corp OCX Maintain Speculative Buy
(N/A)
 
 
  Details
3/9/2021 Seelos Therapeutics SEEL Maintain Buy
(N/A)
 
 
  Details
2/5/2021 Neogenomics NEO Maintain Buy
(N/A)
 
 
  Details
1/19/2021 STAAR Surgical STAA Downgrade Hold
(Buy)
90.99
(154.30)
69.58% Details
1/7/2021 Harvard Bioscience Inc. HBIO Upgrade Buy
(Speculative Buy)
4.27
(7.50)
75.64% Details
1/7/2021 OncoCyte Corp OCX Upgrade Buy
(Speculative Buy)
2.53
(5.72)
126.09% Details
7/1/2020 Invitae Corporation NVTA Downgrade Hold
(Buy)
30.29
(33.77)
11.49% Details
6/17/2020 Chembio Diagnostics CEMI Downgrade Hold
(Buy)
9.93
(3.09)
-68.88% Details
4/2/2020 Flexion Therapeutics FLXN Maintain Buy
(N/A)
 
 
  Details
3/20/2020 LHC Group LHCG Maintain Buy
(N/A)
 
 
  Details
3/4/2020 Chembio Diagnostics CEMI Maintain Speculative Buy
(N/A)
 
 
  Details
2/28/2020 Neogenomics NEO Maintain Buy
(N/A)
 
 
  Details
12/27/2019 Flexion Therapeutics FLXN Maintain Buy
(N/A)
 
 
  Details
12/9/2019 Harvard Bioscience Inc. HBIO Downgrade Speculative Sell
(Buy)
2.94
(7.50)
155.1% Details
11/20/2019 Biofrontera AG BFRA Maintain Buy
(N/A)
 
 
  Details
11/19/2019 STAAR Surgical STAA Maintain Buy
(N/A)
 
 
  Details
10/15/2019 Hoth Therapeutics HOTH New Coverage Speculative Buy
(N/A)
4.24
(1.60)
-62.26% Details
9/26/2019 Orgenesis ORGS New Coverage Speculative Sell
(N/A)
4.20
(5.14)
22.38% Details
9/23/2019 Exact Sciences EXAS Upgrade Buy
(Hold)
103.97
(128.83)
23.91% Details
7/31/2019 Neogenomics NEO Maintain Buy
(N/A)
 
 
  Details
5/9/2019 Flexion Therapeutics FLXN Upgrade Buy
(Hold)
10.24
(9.24)
-9.77% Details
1/4/2019 Flexion Therapeutics FLXN Downgrade Hold
(Buy)
12.46
(10.24)
-17.82% Details
11/1/2018 Neogenomics NEO Maintain Buy
(N/A)
 
 
  Details
9/5/2018 Exact Sciences EXAS New Coverage Hold
(N/A)
77.60
(103.97)
33.98% Details